Research Analysts Offer Predictions for Neogen Q2 Earnings

Neogen Corporation (NASDAQ:NEOG) – Zacks Research lifted their Q2 2027 earnings per share (EPS) estimates for Neogen in a research report issued on Thursday, August 20th. Zacks Research analyst Team now expects that the company will post earnings per share of $0.08 for the quarter, up from their prior forecast of $0.07. The consensus estimate for Neogen’s current full-year earnings is $0.25 per share. Zacks Research also issued estimates for Neogen’s Q3 2027 earnings at $0.06 EPS, Q4 2027 earnings at $0.07 EPS, Q1 2028 earnings at $0.05 EPS, Q3 2028 earnings at $0.07 EPS, Q4 2028 earnings at $0.09 EPS and FY2028 earnings at $0.29 EPS.

Several other equities analysts also recently commented on NEOG. Piper Sandler upgraded shares of Neogen from a “neutral” rating to an “overweight” rating in a report on Wednesday. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Weiss Ratings raised shares of Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Neogen presently has an average rating of “Hold” and an average target price of $11.67.

Neogen Trading Up 0.3%

Shares of Neogen stock opened at $11.64 on Wednesday. The business has a fifty day simple moving average of $10.31 and a two-hundred day simple moving average of $9.84. Neogen has a 1 year low of $4.90 and a 1 year high of $12.85. The company has a market capitalization of $2.54 billion, a price-to-earnings ratio of -388.00, a P/E/G ratio of 4.58 and a beta of 1.77. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.82 and a quick ratio of 2.91.

Neogen (NASDAQ:NEOG) last posted its earnings results on Thursday, July 30th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.03. The business had revenue of $225.30 million for the quarter, compared to analyst estimates of $212.35 million. Neogen had a positive return on equity of 2.78% and a negative net margin of 0.91%.The firm’s revenue was down .1% compared to the same quarter last year. During the same period in the previous year, the firm earned ($2.82) EPS.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Neogen during the 2nd quarter worth $123,000. California State Teachers Retirement System lifted its holdings in shares of Neogen by 773.7% during the second quarter. California State Teachers Retirement System now owns 2,127,196 shares of the company’s stock worth $19,123,000 after buying an additional 1,883,719 shares in the last quarter. Azimuth Capital Investment Management LLC boosted its position in shares of Neogen by 12.3% in the second quarter. Azimuth Capital Investment Management LLC now owns 101,300 shares of the company’s stock valued at $911,000 after acquiring an additional 11,100 shares during the period. Old Mission Investment Co LLC bought a new stake in shares of Neogen in the second quarter valued at about $347,000. Finally, Nykredit A S bought a new stake in shares of Neogen in the second quarter valued at about $28,000. 96.73% of the stock is owned by institutional investors and hedge funds.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.